Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MARSseq of the artificial IFN-I receptor VS HeLa treated with IFN-beta

ABSTRACT: MARSseq experiment demonstrated that engaging the artificial AIR receptor system induced very similar transcriptional changes and upregulation of interferon response genes compared to treatment with native IFN-β, validating the ability of AIR to mimic the natural IFN-I receptor functionally.

ORGANISM(S): Homo sapiens

PROVIDER: GSE264046 | GEO | 2026/01/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

MARSseq of the artificial IFN-I receptor VS HeLa treated with IFN-beta

Project description:MARSseq of the artificial IFN-I receptor VS HeLa treated with IFN-beta

| PRJNA1100597 | ENA

Comparison of gene expression in HeLa cells after treatment with IFN-b, IFN-g, or VPgEMCV.

Project description:We uncovered that cells infected with the encephalomyocarditis virus (EMCV) release soluble factors that induce apoptosis in uninfected cells. These factors were identified as the cytokine TNF-α and the viral protein VPgEMCV, which is necessary for viral RNA synthesis. Intriguingly, we discovered that VPgEMCV also acts as a functional mimic of IFN-γ, activating its canonical signaling pathway. This includes phosphorylation of STAT1 and the induction of IRF-1 and iNOS, leading to increased nitric oxide (NO) production. The synergy of NO accumulation and TNF-α signaling initiates powerful apoptosis. To compare gene sets regulated by IFN-I signaling (IFN-b), IFN-II signaling (IFN-g), and VPgEMCV signaling, we utilized RNA-seq analysis. From the deep sequencing data, we further discovered that VPgEMCV induces a gene expression profile similar to IFN-II signaling (IFN-γ), while also uniquely downregulating a distinct subset of genes. Our findings reveal that this cytokine-mimicry function of VPgEMCV regulates genes to control both viral replication and disease pathogenesis.

2025-10-31 | GSE286568 | GEO

Artificial Immune Receptors as novel tools to engineer inflammation sensing regulatory T cells for cell therapy

Project description:Engineered regulatory T cell (Treg) therapy is a promising strategy to treat patients suffering from inflammatory diseases and autoimmunity. In this study, we introduce a new class of synthetic sensors, named Artificial Immune Receptors (AIRs), for murine and human Treg cells that provide new features to this cell type. AIRs bind inflammatory ligands of the TNF-receptor superfamily and translate this environmental signal into a T cell receptor (TCR)-like program, leading to activation and proliferation of the Treg cells. In a preclinical graft-versus-host-disease model, AIR-Treg cells recognizing lymphotoxin-beta-receptor ligands protect significantly better than Treg cells with only a natural TCR repertoire. Expression and signaling of a human AIR construct in human Treg cells prove that the concept can be translated. Inflammation sensing AIR-Treg cells could be an off-the-shelf Treg cell therapy approach without the knowledge of a specific antigen driving the inflammatory process.

2022-09-12 | GSE197477 | GEO

Artificial Sweeteners

Project description:Artificial Sweeteners

| PRJEB91054 | ENA

The effect of artificial microRNA p-27-5p on breast cancer cells

Project description:MicroRNAs are a group of non-coding small RNAs with lengths around 21~23nt and function as inhibitors to repress mRNA translation by targeting their 3' untranslated region. Recent research shows that microRNAs are involved in many biological processes such as cell growth, development and cancer, etc. Here, we introduce a novel artificial microRNA p-27-5p which can inhibit cell proliferation in breast cancer cell lines. This data shows the expression changes in breast cancer cell line T-47D with the effect of artificial miR-p-27-5p. 4 total samples were analyzed. We generated mimic/control paired samples with 2 repeats.

2013-04-15 | E-GEOD-28657 | biostudies-arrayexpress

HeLa cells: control vs IFN-gamma-treated

Project description:Transcriptional profiling of HeLa cells comparing control untreated HeLa cells with IFN-gamma-treated HeLa cells To infect host cells, many viruses use small cellular compartments, called endosomes, for entry, and the thiol/disulfide interchange in viral envelope glycoproteins (Envs) is crucial for infection. By screening cysteine-reacting chemicals, we found a compound, 4,4’-dithiopyridine, which is active at acidic pH, efficiently restricts retrovirus vector infection. We thus hypothesized that some products of endosome-localized, interferon-stimulated genes (ISGs) exhibit anti-viral activity by inhibiting thiol/disulfide interchange in viral Envs. Among the hundreds of ISGs, gamma-interferon (IFN)-inducible lysosomal thiolreductase (GILT) is the only molecule that resides in the endosomes/lysosomes and digests the S-S bonds of proteins under acidic conditions. We now report that GILT significantly inhibits the replication of retroviruses, including HIV-1 and MLV, by restricting both the early and late phases of their life cycles. Using the VSV-G pseudotyped HIV-1 model, we found that GILT digests the S-S bonds of viral Env proteins. GILT also inhibits HIV-1 viral release by digesting the S-S bond of CD63, an endosome-localized molecule reportedly involved in HIV-1 particle release. The effect of -IFN on HIV-1 is limited, although GILT induced by gamma-IFN is supposed to have anti-HIV-1 activity. We found that while gamma-IFN effectively inhibits MLV replication through GILT, the gamma-IFN signaling is remarkably inhibited by the HIV-1 Env protein, but not the MLV Env protein. These findings suggest that GILT functions as an anti-viral host factor induced by gamma-IFN, however, HIV-1 may have evolved to inhibit gamma-IFN signaling by the Env protein.

2017-01-01 | GSE79568 | GEO

Artificial rumen

Project description:Artificial rumen Targeted loci

| PRJNA560951 | ENA

Human FcgRIIa mediates attenuation of IFN-I response in human monocytes

Project description:It is generally believed that there is continued cross-regulation between adaptive humoral immunity and Type I interferon (IFN-I) response during viral infections, but the question how antibodies (Abs), and/or Ab-antigen immunocomplexes (ICs), regulate IFN-I production and/or signaling in immune cells remains unanswered. Here we report that plate-coated IgG (cIgG), a mimic IC without antigen restriction, could dampen IFN-I signaling in monocytes through FcgRIIa.

2024-12-10 | GSE190623 | GEO

The effects of terbutaline or GW9508 on TNF-alpha and IFN gamma (TNF-alpha + IFN gamma) stimulation by HaCaT

Project description:G-protein coupled receptors (GPCRs) have diverse roles in physiological processes, including immunity. Gs-coupled GPCRs increase while Gi-coupled ones decrease intracellular cAMP. Previous studies suggest that, in epithelial cells, Gs-coupled GPCRs enhance whereas Gi-coupled GPCRs suppress pro-inflammatory immune responses. In order to examine the issue, we chose beta2 adrenergic receptor and GPR40 as representatives of Gs- and Gi- coupled GPCRs, respectively, and examined their effects on TNF-alpha and IFN-gamma-(TNF-alpha + IFN-gamma) induced gene expression by HaCaT. We used microarrays to detail the global changes of gene expression induced by a beta2 adrenergic receptor agonist terbutaline or GPR40 agonist GW9508 pre-treatment in TNF-alpha + IFN-gamma - stimulated HaCaT cells. HaCaT cells were pre-treated with terbutaline or GW9508, TNF-alpha + IFN-gamma were then added, and cultured for another 24 h. Cells were then used for RNA extraction and hybridization on Affymetrix microarrays. We sought to clarify changes in gene expression after 1) TNF-alpha + IFN-gamma, 2) TNF-alpha + IFN-gamma + terbutaline, and 3) TNF-alpha + IFN-gamma + GW9508 treatment. To this end, we set 4 groups of samples; 1) unstimulated group, 2) TNF-alpha + IFN-gamma-stimulated group, 3) TNF-alpha + IFN-gamma + terbutaline-stimulated group, and 4) TNF-alpha + IFN-gamma + GW9508-stimulated group. In each group, HaCaT cells were stimulated in triplicate wells (n=3).

2010-12-01 | E-GEOD-20297 | biostudies-arrayexpress

Negative feedback of IFN-I signaling through IFN-competent RIG-I-like receptor-induced HSPA6

Project description:Negative feedback of IFN-I signaling through IFN-competent RIG-I-like receptor-induced HSPA6

| PRJNA1057862 | ENA